Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee Arthroplasty
Norepinephrine, Glypressin, Tourniquet Deflation, Hypotension
About this trial
This is an interventional prevention trial for Norepinephrine, Glypressin, Tourniquet Deflation
Eligibility Criteria
Inclusion Criteria: Adult Patients of both gender American Society of Anesthesiologists (ASA) I or II scheduled for elective unilateral total knee arthroplasty Exclusion Criteria Patient refusal. Major cardiopulmonary disorders Uncontrolled systemic hypertension. Hepatic or renal disorders. Patient with relative contraindication for tourniquet use as peripheral vascular disease, sickle cell anemia, deep venous thrombosis, diabetic neuropathy and crushed injury. Cases having American Society of Anesthesiologists [ASA] > II Coagulopathy and bleeding tendency. Revision knee arthroplasty and bilateral knee arthroplasty
Sites / Locations
- Faculty of medicine, Tanta universityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
control
noradrenaline
glypressin